Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Guttman

Showing results (171-180 of 387) with videos related to

Pageof 39
Sort By:
Journal of the American Academy of Dermatology|December 25, 2019
Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathwaysMichelle S Min, Jianni Wu, Helen He, et al.
The Journal of Investigative Dermatology|October 25, 2016
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic DisorderPatrick M Brunner, Jonathan I Silverberg, Emma Guttman-Yassky, et al.
The Journal of Allergy and Clinical Immunology|May 3, 2007
Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasisEmma Guttman-Yassky, Michelle A Lowes, Judilyn Fuentes-Duculan, et al.
The Journal of Allergy and Clinical Immunology|September 30, 2023
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligoEmma Guttman-Yassky, Ester Del Duca, Joel Correa Da Rosa, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 4, 2017
Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging TherapiesMark Boguniewicz, Andrew F Alexis, Lisa A Beck, et al.
JAMA Dermatology|April 15, 2026
International Eczema Council Definitions of Low Disease Activity and Remission in Atopic Dermatitis: A Consensus StatementJoseph F Merola, Beth A Childs, Brooke R Bartley, et al.
The Journal of Allergy and Clinical Immunology|March 10, 2015
Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell populationTali Czarnowicki, Juana Gonzalez, Avner Shemer, et al.
The Journal of Investigative Dermatology|October 16, 2025
Randomized Controlled Trial of the Topical Jak Inhibitor Delgocitinib Cream in Patients with Frontal Fibrosing AlopeciaAubrey Martin, Neda Shokrian, Kristen J Kelley, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 10, 2026
Hematologic Patterns in Differentiating DRESS From Morbilliform Drug Eruptions: A Preliminary InvestigationGrace Rabinowitz, Austin Piontkowski, Benjamin Shwartzman, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysisEmma Guttman-Yassky, Mayte Suárez-Fariñas, Andrea Chiricozzi, et al.
Pageof 39

Showing results (171-180 of 387) with videos related to

Sort By:
Pageof 39
Journal of the American Academy of Dermatology|December 25, 2019
Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathwaysMichelle S Min, Jianni Wu, Helen He, et al.
The Journal of Investigative Dermatology|October 25, 2016
Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic DisorderPatrick M Brunner, Jonathan I Silverberg, Emma Guttman-Yassky, et al.
The Journal of Allergy and Clinical Immunology|May 3, 2007
Major differences in inflammatory dendritic cells and their products distinguish atopic dermatitis from psoriasisEmma Guttman-Yassky, Michelle A Lowes, Judilyn Fuentes-Duculan, et al.
The Journal of Allergy and Clinical Immunology|September 30, 2023
Improvements in immune/melanocyte biomarkers with JAK3/TEC family kinase inhibitor ritlecitinib in vitiligoEmma Guttman-Yassky, Ester Del Duca, Joel Correa Da Rosa, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 4, 2017
Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging TherapiesMark Boguniewicz, Andrew F Alexis, Lisa A Beck, et al.
JAMA Dermatology|April 15, 2026
International Eczema Council Definitions of Low Disease Activity and Remission in Atopic Dermatitis: A Consensus StatementJoseph F Merola, Beth A Childs, Brooke R Bartley, et al.
The Journal of Allergy and Clinical Immunology|March 10, 2015
Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell populationTali Czarnowicki, Juana Gonzalez, Avner Shemer, et al.
The Journal of Investigative Dermatology|October 16, 2025
Randomized Controlled Trial of the Topical Jak Inhibitor Delgocitinib Cream in Patients with Frontal Fibrosing AlopeciaAubrey Martin, Neda Shokrian, Kristen J Kelley, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|March 10, 2026
Hematologic Patterns in Differentiating DRESS From Morbilliform Drug Eruptions: A Preliminary InvestigationGrace Rabinowitz, Austin Piontkowski, Benjamin Shwartzman, et al.
The Journal of Allergy and Clinical Immunology|December 17, 2009
Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysisEmma Guttman-Yassky, Mayte Suárez-Fariñas, Andrea Chiricozzi, et al.
Pageof 39